5 authorised products containing Irinotecan hydrochloride trihydrate, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| CAMPTO 20 mg/mL concentrate for solution for infusion PA0822/212/001 |
Irinotecan hydrochloride trihydrate | Pfizer Healthcare Ireland Unlimited Company | Not marketed |
| Irinotecan 20 mg/ml Concentrate for solution for infusion PA2059/044/001 |
Irinotecan hydrochloride trihydrate | Fresenius Kabi Deutschland GmbH | Marketed |
| Irinotecan Hydrochloride 20 mg/ml Concentrate for Solution for Infusion PA2315/108/001 |
Irinotecan hydrochloride trihydrate | Accord Healthcare Ireland Ltd. | Marketed |
| Irinotecan Hydrochloride 20 mg/mL concentrate for solution for infusion PA1986/068/001 |
Irinotecan hydrochloride trihydrate | Teva B.V. | Marketed |
| ONIVYDE pegylated liposomal 4.3 mg/ml concentrate for dispersion for infusion EU/1/16/1130/001 |
Irinotecan hydrochloride trihydrate | Les Laboratoires Servier | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.